Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

Three key takeaways from the Pan-European Procurement Summit

A common refrain at the Pan-European Procurement Summit in Brussels was that price and quality are the two biggest concerns for procurement professionals. HBI heard plenty on price – especially price transparency – but rather than quality, attention turned to the growing concerns of sustainability and digitalisation.

Interview: Dieter Zocholl, founder and CEO of XMED iQ

Dieter Zocholl is a man on a mission. On the first day of the healthcare procurement conference in Brussels, the founder and CEO of procurement specialist XMED iQ argued passionately for more price transparency in the procurement of healthcare devices. But while the host of the recent Procurement Conference in Brussels poked gentle, good-natured fun at him, Zocholl presented an interesting problem.

ESG now ‘essential’ for health care companies

Last month we discussed whether ESG has the ability to transform capitalism, or whether it amounts to little more than a corporate PR exercise. Two people who may be able to help us answer this question in relation to health care specifically are Guyon Stams, director in the healthcare sector team, and Joost van Dun, director of sustainable finance, at Dutch multinational bank ING, both of whom focus on supporting health care clients align their ESG strategies with their financing. Stams tells us ESG has become an ‘essential’ consideration for health care companies. 

Interview: Julien Samson, CEO, Groupe Maisons de Famille

Julien Samson, recently appointed CEO of the European care homes group Groupe Maisons de Famille, has some creative ideas on how to manage the business. In the face of industry-wide criticism and concern following hard-hitting headlines about rivals Orpea and Korian, he still believes the industry can find ways to cope with the persistent pandemic, the energy crisis and inflationary recession.

German nursing homes: safe as houses?

For many years investors have piled into German nursing homes attracted by the long-term care insurance payment model which guarantees future budgets. But the current wave of inflation may swamp many operators.

Consolidation opportunity in post-Covid Dutch labs sector

The Netherlands' diagnostic labs sector is being held back by low tariffs, which are resulting in low margins meaning there is little incentive to invest in the sector. HBI speaks to an operator who thinks as Covid support wanes, we may see a lot of consolidation.

Synlab still benefiting from Covid testing windfall

Europe’s largest lab group Synlab earned €618m from Covid testing in the first half of 2022. This was a 30% drop from H1 2021, but higher than what it had initially forecasted for the period. Revenue from underlying, non-Covid activity was strong, at 7.2%, helped by several bolt-on acquisitions.

Find Us